Suppression of the TRIF-dependent signaling pathway of toll-like receptor by triptolide

Toxicology and Environmental Health Sciences

Volumn 5, Issue 4, 2013, Pages 177-182

  Gu, Gyo Jeong ^a   Youn, Hyung Sun ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

lipopolysaccharide; polyinosinic polycytidylic acid; Toll like receptors; TRIF; triptolide

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRIPTOLIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSFECTION; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84893620438     PISSN: 20059752     EISSN: 22337784     Source Type: Journal    
DOI: 10.1007/s13530-013-0173-6     Document Type: Article

References (28)

1. Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature388, 394-397 (1997).
2. Bjorkbacka, H. et al. The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades. Physiol. Genomics19, 319-330 (2004).
3. O'Neill, L. A. & Bowie, A. G. The family of five: TIRdomain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7, 353-364 (2007).
4. Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384 (2010).
5. Takeda, K. & Akira, S. Toll-like receptors in innate immunity. Int. Immunol. 17, 1-14 (2005).
6. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell124, 783-801 (2006).
7. Fitzgerald, K. A. et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491-496 (2003).
8. Kawai, T. et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167, 5887-5894 (2001).
9. Gao, J. J. et al. Autocrine/paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene. J. Immunol. 161, 4803-4810 (1998).
10. Jiang, X. Clinical observations on the use of the Chinese herb Tripterygium wilfordii Hook for the treatment of nephrotic syndrome. Pediatr. Nephrol. 8, 343-344 (1994).
11. Chen, B. J. Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. Leuk. Lymphoma42, 253-265 (2001).
12. Tao, X. L. et al. A prospective, controlled, doubleblind, cross-over study of tripterygium wilfodii hook F in treatment of rheumatoid arthritis. Chin. Med. J. (Engl)102, 327-332 (1989).
13. Qiu, D. & Kao, P. N. Immunosuppressive and antiinflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R&D4, 1-18 (2003).
14. Jiao, J. et al. Triptolide inhibits amyloid-beta1-42-induced TNF-alpha and IL-1beta production in cultured rat microglia. J. Neuroimmunol. 205, 32-36 (2008).
15. Lu, Y. et al. Inhibitory effect of triptolide on chemokine expression induced by proinflammatory cytokines in human corneal fibroblasts. Invest Ophthalmol. Vis. Sci. 46, 2346-2352 (2005).
16. Kim, Y. H. et al. Triptolide inhibits murine-inducible nitric oxide synthase expression by down-regulating lipopolysaccharide-induced activity of nuclear factorkappa B and c-Jun NH2-terminal kinase. Eur. J. Pharmacol. 494, 1-9 (2004).
17. Geng, Y. et al. Triptolide down-regulates COX-2 expression and PGE2 release by suppressing the activity of NF-kappaB and MAP kinases in lipopolysaccharidetreated PC12 cells. Phytother. Res. 26, 337-343 (2012).
18. Yoneyama, M. et al. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. Embo J. 17, 1087-1095 (1998).
19. Lin, R., Heylbroeck, C., Pitha, P. M. & Hiscott, J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18, 2986-2996 (1998).
20. Lin, R., Heylbroeck, C., Genin, P., Pitha, P. M. & Hiscott, J. Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol. Cell. Biol. 19, 959-966 (1999).
21. Schafer, S. L., Lin, R., Moore, P. A., Hiscott, J. & Pitha, P. M. Regulation of type I interferon gene expression by interferon regulatory factor-3. J. Biol. Chem. 273, 2714-2720 (1998).
22. Youn, H. S. et al. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J. Immunol. 175, 3339-3346 (2005).
23. Park, S. J. & Youn, H. S. Isoliquiritigenin suppresses the Toll-interleukin-1 receptor domain-containing adapter inducing interferon-beta (TRIF)-dependent signaling pathway of Toll-like receptors by targeting TBK1. J. Agric. Food Chem. 58, 4701-4705 (2010).
24. Youn, H. S. et al. Suppression of MyD88- and TRIFdependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea. Biochem. Pharmacol. 72, 850-859 (2006).
25. Ahn, S. I., Lee, J. K. & Youn, H. S. Inhibition of homodimerization of toll-like receptor 4 by 6-shogaol. Mol. Cells27, 211-215 (2009).
26. Park, S. J. et al. Costunolide inhibits cyclooxygenase-2 expression induced by Toll-like receptor 3 or 4 agonist. Toxicol. Environ. Health Sci. 1, 122-126 (2009).
27. Park, S. J., Lee, M. Y., Son, B. S. & Youn, H. S. TBK1-targeted suppression of TRIF-dependent signaling pathway of Toll-like receptors by 6-shogaol, an active component of ginger. Biosci. Biotechnol. Biochem. 73, 1474-1478 (2009).
28. Youn, H. S. et al. Sulforaphane suppresses oligomerization of TLR4 in a thiol-dependent manner. J. Immunol. 184, 411-419.